Evidence map›Paper›PMID 36352978›Full record

ReviewJournal of family medicine and primary care2022

Needling, lasers, and Meso-Botox for hypertrophic and keloidal scars: A comprehensive review study on promising procedural treatments.

Sara Dilmaghani, Elham Behrangi, Monireh Mazandarani, Ali Pourali, Sara Sadeghi, Mina Khosravi, Azadeh Goodarzi

Open access · goldAbstract readReview
In one paragraph

Review in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Sara DilmaghaniDepartment of Dermatology, Rasool Akram Medical Complex, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Elham BehrangiDepartment of Dermatology, Rasool Akram Medical Complex, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Monireh MazandaraniDepartment of General Medicine, Shahroud University of Medical Sciences, Shahroud, Semnan, Iran.
Ali PouraliDepartment of General Medicine, Guilan University of Medical Sciences, Rasht, Guilan, Iran.
Sara SadeghiSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mina KhosraviIntern, Iran University of Medical Sciences, Tehran, Iran.
Azadeh GoodarziDepartment of Dermatology, Rasool Akram Medical Complex, School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Iran University of Medical Sciences · IRGuilan University of Medical Sciences · IRShahroud University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scars are among the most prevalent referral cases of dermatology clinics, including atrophic, hypertrophic, or keloidal scars. Approach to scar usually needs a holistic trend, attention to individualized characteristics, and combination therapy. Scars usually need multiple sessions of therapy and the use of combination therapeutic approaches to reach the most acceptable outcomes by safe modalities. Studies on scars are always one of the most important fields of research in medicine, especially in dermatology. For writing this review study, we searched all the databases to find the most relevant and the newest studies related to our topic, because based on expert opinion, this topic may be really practical and interesting for dermatologists and all physicians of various specialties or subspecialties who manage and treat various kinds of scars, including hypertrophic scars and keloids. Based on our results, we concluded that different procedures, which basically use needling, lasers, especially pulsed dye laser (PDL) and carbon dioxide (CO

Indexed as

Botulinum Toxinlasermicroneedlingneedlingscar

Identifiers

PMID36352978
PMCPMC9638564
OpenAlexW4295345810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.